Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517336 | SCV000613903 | uncertain significance | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000767168 | SCV000621765 | uncertain significance | not provided | 2021-04-14 | criteria provided, single submitter | clinical testing | In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001083254 | SCV000638546 | likely benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848888 | SCV002104830 | uncertain significance | Hereditary spastic paraplegia | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737586 | SCV005352439 | likely benign | KIF1A-related disorder | 2024-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |